Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeoVax Labs (GOVX) Gains from Investment Securities (2016 - 2025)

GeoVax Labs (GOVX) has disclosed Gains from Investment Securities for 15 consecutive years, with $1.1 million as the latest value for Q3 2025.

  • On a quarterly basis, Gains from Investment Securities rose 241.36% to $1.1 million in Q3 2025 year-over-year; TTM through Sep 2025 was $1.1 million, a 241.36% increase, with the full-year FY2024 number at $333648.0, changed 0.0% from a year prior.
  • Gains from Investment Securities was $1.1 million for Q3 2025 at GeoVax Labs, up from $805300.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $2.1 million in Q1 2023 to a low of $133648.0 in Q1 2024.
  • A 5-year average of $893788.9 and a median of $883800.0 in 2021 define the central range for Gains from Investment Securities.
  • Peak YoY movement for Gains from Investment Securities: tumbled 93.51% in 2024, then skyrocketed 752.2% in 2025.
  • GeoVax Labs' Gains from Investment Securities stood at $962300.0 in 2021, then crashed by 85.73% to $137276.0 in 2022, then surged by 143.05% to $333648.0 in 2023, then changed by 0.0% to $333648.0 in 2024, then skyrocketed by 241.36% to $1.1 million in 2025.
  • Per Business Quant, the three most recent readings for GOVX's Gains from Investment Securities are $1.1 million (Q3 2025), $805300.0 (Q2 2025), and $1.1 million (Q1 2025).